Clinical trial Recruiting at 1 site Observational

New technology for identifying respiratory viruses

Official title: ResVir Novel Technologies for Respiratory Virus Identification

Run by Portsmouth Hospitals NHS Trust · NCT05661032 · Data updated 2026-11-12

This study is testing a new technology that quickly identifies different respiratory viruses from throat swabs to see if it can help doctors manage infections better.

Quick facts

Study typeObservational
SexAll
Enrollment1000 (estimated)
SponsorPortsmouth Hospitals NHS Trust
Government
Locations1 site (Portsmouth, Hampshire)
StatusRecruiting
StartedJanuary 18, 2023
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedSeptember 17, 2026
Trial IDNCT05661032 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with clinical suspicion of a respiratory viral infection who can provide nasopharyngeal swab specimens.

Probably not a fit

Patients who are unable to provide nasopharyngeal swabs or those lacking the capacity to consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of the Pictura Bio system, a novel rapid pathogen identification technology, in detecting and differentiating respiratory viruses from nasopharyngeal swabs. The study will collect data to train algorithms that enhance the accuracy of virus identification. By monitoring the system's performance over time, researchers hope to improve its sensitivity and specificity for clinical use. The ultimate goal is to provide a rapid, cost-effective diagnostic tool that can help manage respiratory infections more effectively.

Why it matters

Potential benefit: If successful, this technology could lead to faster and more accurate diagnoses of respiratory infections, reducing unnecessary antibiotic use and improving patient outcomes.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving rapid virus detection methods.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Provide informed, (parental/guardian, where appropriate) consent
* Able to provide nasopharyngeal swab/aspirate specimens.
* A clinical suspicion of a respiratory viral infection with one or more of the following symptoms:
* Coryzal symptoms (runny nose, sneezing and/or nasal congestion)
* New onset of cough
* Sore throat
* Head and/or Muscle aches
* Fever or chills

Exclusion Criteria:

* Unable to comply with study procedures or where in the opinion of the investigator, undertaking a nasopharyngeal swab may be detrimental to the individual
* Lacking capacity to consent

Where it's running

  • Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital
    Portsmouth, Hampshire, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.